03.22.12
William P. Botha has been appointed president of Avrio Biopharmaceuticals, LLC. Mr. Botha has more than 24 years of direct experience in manufacturing and the pharmaceutical, biotech, and medical device industries.
Mr. Botha has a proven track record exhibiting core strengths in GMP, GDP, bulk production, purification, filling, lyophilization, labeling, device assembly, packaging, fractionation, perfusion, and field inventory management. Prior to joining the company, Mr. Botha served as senior director of operational excellence at Genzyme Corp. and as a plant manager and director of Pharmaceutical Manufacturing at Baxter Healthcare.
"I am very excited to welcome William to the Avrio team. William brings an important combination of strategic, financial, and operational experience. I am certain that he will play a critical role in the success of our organization," said Assad J. Kazeminy, Ph.D., chief executive officer and founder of Avrio.
Mr. Botha has a proven track record exhibiting core strengths in GMP, GDP, bulk production, purification, filling, lyophilization, labeling, device assembly, packaging, fractionation, perfusion, and field inventory management. Prior to joining the company, Mr. Botha served as senior director of operational excellence at Genzyme Corp. and as a plant manager and director of Pharmaceutical Manufacturing at Baxter Healthcare.
"I am very excited to welcome William to the Avrio team. William brings an important combination of strategic, financial, and operational experience. I am certain that he will play a critical role in the success of our organization," said Assad J. Kazeminy, Ph.D., chief executive officer and founder of Avrio.